G9066 Onc diagnosis nsclc stg3b-4 metasta
Also known as: NSCLC advanced metastatic, stage 4 lung cancer
Performance measure documenting diagnosis of Non-Small Cell Lung Cancer (NSCLC) stage IIIB-IV with distant metastasis.
In Plain Language
advanced lung cancer that has spread; stage 3b or 4 non-small cell lung cancer
Clinical Context
Quality measure documenting advanced NSCLC with metastatic disease for palliative treatment planning.
RVU Information
CPT G9066 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
G-codes are CMS-specific HCPCS codes for services not covered by standard CPT. Documentation requirements follow the same standards as the equivalent CPT service. Check Medicare LCD/NCD policies for coverage criteria.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the G Codes category, 85% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code G9066?
CPT G9066 (Onc diagnosis nsclc stg3b-4 metasta) is a G Codes code. Performance measure documenting diagnosis of Non-Small Cell Lung Cancer (NSCLC) stage IIIB-IV with distant metastasis.
Who uses CPT code G9066?
CPT G9066 is used by Thoracic Oncology, Pulmonary Medicine. Quality measure documenting advanced NSCLC with metastatic disease for palliative treatment planning.
When is CPT G9066 used?
Quality measure documenting advanced NSCLC with metastatic disease for palliative treatment planning.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.